RevMed

Meridian Bioscience Canada Inc 410200 Revogene® GBS LB

Company Name
Meridian Bioscience Canada Inc
Catalog Number
410200
UOMs
  • Each

Description

The Revogene® GBS LB assay performed on the Revogene instrument is a qualitative in vitro diagnostic test designed to detect Group B Streptococcus (GBS) DNA from 18-24 hour LIM broth enrichments of vaginal/rectal specimen swabs obtained from pregnant women. The Revogene GBS LB assay utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect a cfb gene sequence specific to the Streptococcus agalactiae genome.The Revogene GBS LB assay is indicated for the identification of antepartum GBS colonization and does not provide susceptibility results. It is not intended to diagnose or monitor treatment of GBS infection. Culture isolates are needed for performing susceptibility testing as recommended for penicillin-allergic women.
Have questions, or need more information? Contact Us

Pricing
Summary

Price Not Available
Out of Stock
Interested in this product?
Contact us or login to add to your watchlist.

Related Items

Additional Details

Device Identifier
00628055344117
Is RX
Yes
Is Over the Counter
No
Requires Sterilization
No
Is Sterile
No
Is Single Use
Yes

Barcode Mapping

Unit of MeasurementEachesGTIN
Each100628055344117